Trial Profile
Phase II Trial of Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Tremelimumab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 07 Jun 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
- 07 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jan 2011 Planned end date (Sep 2011) added as reported by ClinicalTrials.gov.